Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial
围手术期替雷利珠单抗联合化疗治疗局部晚期胃食管交界处腺癌（NEOSUMMIT-03）：一项前瞻性、非随机、开放标签的II期试验
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02160-8
Nie, Run-Cong; Yuan, Shu-Qiang; Ding, Ya; Chen, Yong-Ming; Li, Yuan-Fang; Liang, Cheng-Cai; Cai, Mu-Yan; Chen, Guo-Ming; Wang, Wei; Sun, Xiao-Wei; Weng, De-Sheng; Li, Dan-Dan; Zhao, Jing-Jing; Chen, Xiao-Jiang; Guan, Yuan-Xiang; Liu, Zhi-Min; Liang, Yao; Luo, Ma; Chi, Jun; Qiu, Hai-Bo; Zhou, Zhi-Wei; Zhang, Xiao-Shi; Chen, Ying-Bo
